Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 131

    1.

    The Diabetes Prevention Program and the metabolic syndrome.

    Anania FA, Parekh S, Shaukat A.

    Ann Intern Med. 2005 Oct 4;143(7):545; author reply 545-6. No abstract available. PMID: 16204173 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The Diabetes Prevention Program and the metabolic syndrome.

    Sarinas PS, Dube DS.

    Ann Intern Med. 2005 Oct 4;143(7):544-5; author reply 545-6. No abstract available. PMID: 16204171 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summaries for patients. The effect of diet and exercise or metformin on the metabolic syndrome.

    [No authors listed]

    Ann Intern Med. 2005 Apr 19;142(8):I46. No abstract available. PMID: 15838061 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.

    Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.

    J Am Acad Nurse Pract. 2007 Jul;19(7):368-77.PMID: 17680902 [PubMed - indexed for MEDLINE]Related articles

    5.

    Review article: the treatment of fatty liver disease associated with the metabolic syndrome.

    Marchesini G, Natale S, Manini R, Agostini F.

    Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:37-9. Review.PMID: 16225470 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Treatment of fatty liver disease]

    Cobo Martín M, Fernández Gil P, Crespo J.

    Gastroenterol Hepatol. 2008 Apr;31(4):229-38. Review. Spanish. PMID: 18405489 [PubMed - indexed for MEDLINE]Related articles

    7.

    Metformin: effective in the prevention of new-onset type 2 diabetes?

    Drown DJ.

    Prog Cardiovasc Nurs. 2008 Spring;23(2):93-4. No abstract available. PMID: 18843833 [PubMed - indexed for MEDLINE]Related articles

    8.

    Optimal treatments for the metabolic syndrome.

    Giugliano D, Esposito K.

    Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):e30. No abstract available. PMID: 16556857 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease.

    Kadayifci A, Merriman RB.

    Am J Gastroenterol. 2006 Jun;101(6):1396; author reply 1396-7. No abstract available. PMID: 16771968 [PubMed - indexed for MEDLINE]Related articles

    10.

    Striving for a more active community. Lessons from the diabetes prevention program and beyond.

    Kriska A.

    Am J Prev Med. 2002 May;22(4 Suppl):6-7. No abstract available. PMID: 11985930 [PubMed - indexed for MEDLINE]Related articles

    11.

    Unmet needs in controlling metabolic disease.

    Haffner SM.

    Rev Cardiovasc Med. 2007;8 Suppl 4:S17-24. Review.PMID: 17934390 [PubMed - indexed for MEDLINE]Related articles

    12.

    Diabetes prevention program: education is vital.

    Fain JA.

    Diabetes Educ. 2002 Jul-Aug;28(4):474. No abstract available. PMID: 12224190 [PubMed - indexed for MEDLINE]Related articles

    13.

    Summaries for patients. The outcomes and costs of diabetes prevention with a diet and exercise program or metformin: a computer model.

    [No authors listed]

    Ann Intern Med. 2005 Aug 16;143(4):I22. No abstract available. PMID: 16103465 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    [Diagnosis of and therapy for nonalcoholic steatohepatitis]

    Onishi S, Saibara T.

    Nippon Naika Gakkai Zasshi. 2006 Sep 10;95(9):1876-80. Review. Japanese. No abstract available. PMID: 17037330 [PubMed - indexed for MEDLINE]Related articles

    15.

    Metabolic syndrome: are we at risk?

    Paudel B.

    Nepal Med Coll J. 2007 Sep;9(3):204-11. Review.PMID: 18092442 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment of fibrosis in nonalcoholic fatty liver disease.

    Hoteit MA, Anania FA.

    Curr Gastroenterol Rep. 2007 Mar;9(1):47-53. Review.PMID: 17335677 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Insulin sensitizer--anti-diabetic drugs, metformin and pioglitazone that can improve insulin resistance]

    Korenaga M, Kawaguchi K, Korenaga K, Uchida K, Sakaida I.

    Nippon Rinsho. 2006 Jun;64(6):1157-64. Review. Japanese. PMID: 16768125 [PubMed - indexed for MEDLINE]Related articles

    18.

    The metabolic syndrome--early action to decrease risks for cardiovascular disease.

    Fritschi C, Richlin D.

    AAOHN J. 2004 Aug;52(8):320-2. Review. No abstract available. PMID: 15357369 [PubMed - indexed for MEDLINE]Related articles

    19.

    Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.

    Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF.

    J Clin Pharm Ther. 2006 Aug;31(4):375-83.PMID: 16882108 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Metabolic syndrome, definitions and physiopathology]

    Monnier L, Bénichou M.

    Soins. 2004 Apr;(684 Pt 2):4-7. Review. French. No abstract available. PMID: 15151084 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data